Autism Spectrum Disorder Trial, Recruiting (NCT06386029)

Autism Spectrum Disorder Trial, Recruiting NCT06386029 Sponsor: University of Pittsburgh Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06386029 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child must be between 6 and 10 years old
A parent must have reported that their child has been diagnosed with autism
A parent must have reported that their child has significant and ongoing difficulty settling down at bedtime
A parent must have reported that their child is sensitive to sensory experiences, shown by answering "yes" to at least 8 questions on a sensory checklist
A parent must be willing to take part in a nightly bedtime routine throughout the 2-week study
The family must live in the Pittsburgh area

Who may not be able to join:

Children who do not understand English, or whose family cannot travel to the University of Pittsburgh Medical Center Western Psychiatric Hospital, may not be able to participate
Children for whom physical touch is upsetting or triggering due to trauma or other past experiences (as reported by a caregiver) are not able to join
If the child sleeps at a different caregiver's home more than half of the nights and that caregiver is not willing to take part in the study, the child cannot participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amy G Hartman, PhD, University of Pittsburgh

Phone: 412-648-7997

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06386029

Sponsor: University of Pittsburgh

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: 412-648-7997

More information: https://clinicaltrials.gov/study/NCT06386029

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child must be between 6 and 10 years old
A parent must have reported that their child has been diagnosed with autism
A parent must have reported that their child has significant and ongoing difficulty settling down at bedtime
A parent must have reported that their child is sensitive to sensory experiences, shown by answering "yes" to at least 8 questions on a sensory checklist
A parent must be willing to take part in a nightly bedtime routine throughout the 2-week study
The family must live in the Pittsburgh area

Who may not be able to join:

Children who do not understand English, or whose family cannot travel to the University of Pittsburgh Medical Center Western Psychiatric Hospital, may not be able to participate
Children for whom physical touch is upsetting or triggering due to trauma or other past experiences (as reported by a caregiver) are not able to join
If the child sleeps at a different caregiver's home more than half of the nights and that caregiver is not willing to take part in the study, the child cannot participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Pittsburgh

Registry

ClinicalTrials.gov

Start date

5 July 2025

Est. completion

1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Recruitment rates of participants through the trial; Retention rates of participants through the trial; Caregiver reported acceptability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov